Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease

By M. Lincoff, S. Nicholls, J. Riesmeyer, P. Barter, B. Brewer, K. Fox, M. Gibson, C. Granger, V. Menon, G. Montalescot and 19 more. New England Journal of Medicine, 2017

692 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/ccfcab085171c1f36a68288b8d9aeff55991b998

Citations in the corpus

• Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021, neutral): “180,181”